Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients
Public ClinicalTrials.gov record NCT00042354. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Open Label Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Clofarabine (injection) is approved by the Food and Drug Administration (FDA) for the treatment of pediatric patients 1 to 21 years old with relapsed acute lymphoblastic leukemia (ALL) who have had at least 2 prior treatment regimens. The purpose of this study is to determine whether Clofarabine is safe and effective in the treatment of Acute Myelogenous Leukemia (AML.)
Study identification
- NCT ID
- NCT00042354
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2002 (Type not available)
- Primary completion
- Not listed
- Completion
- Aug 2004 (Actual)
- Last update posted
- Mar 5, 2015
2002 – 2004
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Children's Hospital | Los Angeles | California | 90027 | — |
| Children's Hospital | Orange County | California | — | — |
| Children's Hospital | San Diego | California | — | — |
| Children's Hospital | Denver | Colorado | — | — |
| University of Connecticut Health Center | Hartford | Connecticut | 06106 | — |
| Children's Memorial Hospital | Chicago | Illinois | 60614 | — |
| Johns Hopkins Children's Center | Baltimore | Maryland | 21231 | — |
| Children's Hospital | St Louis | Missouri | — | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 67198 | — |
| Memorial Sloan-Kettering | New York | New York | — | — |
| Children's Hospital | Philadelphia | Pennsylvania | — | — |
| Children's Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| St. Jude Children's Research Hospital | Memphis | Tennessee | — | — |
| Children's Medical Center | Dallas | Texas | — | — |
| Cook's Children's Medical Center | Fort Worth | Texas | 76104 | — |
| Texas Children's Cancer Center | Houston | Texas | — | — |
| The University of Texas M.D. Anderson Cancer Center | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00042354, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2015 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00042354 live on ClinicalTrials.gov.